메뉴 건너뛰기




Volumn 20, Issue 3, 2014, Pages

Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BETAMETHASONE DIPROPIONATE; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CALCITRIOL; CLOBETASOL PROPIONATE; COAL TAR; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; ESTER DERIVATIVE; ETRETIN; FUMARIC ACID; FUMARIC ACID DERIVATIVE; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ESTER DERIVATIVE; INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PIMECROLIMUS; PLACEBO; RETINOID DERIVATIVE; RETINOL; STEROID; TACROLIMUS; TRIMETHOPRIM; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN D; ZINC;

EID: 84896462801     PISSN: 10872108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (42)

References (252)
  • 2
    • 11144327646 scopus 로고    scopus 로고
    • The prevalence of psoriasis in African Americans: Results from a population-based study
    • Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermtol 2005; 52: 23-26.
    • (2005) J Am Acad Dermtol , vol.52 , pp. 23-26
    • Gelfand, J.M.1    Stern, R.S.2    Nijsten, T.3
  • 3
    • 0032872277 scopus 로고    scopus 로고
    • Psoriasis causes as much disability as other major medical diseases
    • Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:401-407.
    • (1999) J Am Acad Dermatol , vol.41 , pp. 401-407
    • Rapp, S.R.1    Feldman, S.R.2    Exum, M.L.3
  • 4
    • 79953894392 scopus 로고    scopus 로고
    • Prevalence of the metabolic syndrome in psoriasis: Results from the national health and nutrition examination survey, 2003-2006
    • Love TJ, Qureshi AA, Karlson EW, et al. Prevalence of the metabolic syndrome in psoriasis: results from the national health and nutrition examination survey, 2003-2006. Arch Dermatol. 2011; 147: 419-424.
    • (2011) Arch Dermatol , vol.147 , pp. 419-424
    • Love, T.J.1    Qureshi, A.A.2    Karlson, E.W.3
  • 5
    • 67349230808 scopus 로고    scopus 로고
    • The IL-23/Th17 axis in the immunopathogenesis of psoriasis
    • Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009; 129: 1339-1350.
    • (2009) J Invest Dermatol , vol.129 , pp. 1339-1350
    • Di Cesare, A.1    Di Meglio, P.2    Nestle, F.O.3
  • 6
    • 7244248799 scopus 로고    scopus 로고
    • The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'
    • Spuls PI, Tuut MK, van Everdingen JJ, et al. The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis'. Ned Tijdschr Geneeskd 2004; 148: 2121-2125.
    • (2004) Ned Tijdschr Geneeskd , vol.148 , pp. 2121-2125
    • Spuls, P.I.1    Tuut, M.K.2    van Everdingen, J.J.3
  • 7
    • 34447136147 scopus 로고    scopus 로고
    • Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris
    • Nast A, Kopp IB, Augustin M, et al. Evidence-based (S3) guidelines for the treatment of psoriasis vulgaris. J Dtsch Dermatol Ges 2007; 5 (Suppl. 3): 1-119.
    • (2007) J Dtsch Dermatol Ges , vol.5 , Issue.SUPPL. 3 , pp. 1-119
    • Nast, A.1    Kopp, I.B.2    Augustin, M.3
  • 8
    • 70249137988 scopus 로고    scopus 로고
    • European S3 guideline on the systemic treatment of psoriasis vulgaris
    • Pathirana D, Omerod AD, Saiag P, et al. European S3 guideline on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23 (Suppl. 2): 1-70.
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , Issue.SUPPL. 2 , pp. 1-70
    • Pathirana, D.1    Omerod, A.D.2    Saiag, P.3
  • 9
    • 80051825605 scopus 로고    scopus 로고
    • The multidisciplinary practice guideline 'The responsible use of biologics'
    • Bijlsma JWJ, Hagemeijer JW, Bijl M, et al. The multidisciplinary practice guideline 'The responsible use of biologics'. Ned Tijdschr Geneeskd. 2011; 155: A3114.
    • (2011) Ned Tijdschr Geneeskd , vol.155
    • Bijlsma, J.W.J.1    Hagemeijer, J.W.2    Bijl, M.3
  • 11
    • 77951939023 scopus 로고    scopus 로고
    • Efficacy and safety of treatments for childhood psoriasis; A systematic literature review
    • de Jager ME, de Jong EM, Mvan de Kerkhof PC, Seyger MM. Efficacy and safety of treatments for childhood psoriasis; A systematic literature review J Am Acad Dermatol. 2010;62:1013-1030.
    • (2010) J Am Acad Dermatol , vol.62 , pp. 1013-1030
    • de Jager, M.E.1    de Jong, E.M.2    de Kerkhof, P.C.M.3    Seyger, M.M.4
  • 13
    • 33744734330 scopus 로고    scopus 로고
    • 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study
    • Ortonne JP, van de Kerkhof PC, Prinz JC, Bieber T, Lahfa M, Rubins A, et al. 0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. Acta Derm Venereol 2006;86(1):29-33.
    • (2006) Acta Derm Venereol , vol.86 , Issue.1 , pp. 29-33
    • Ortonne, J.P.1    van de Kerkhof, P.C.2    Prinz, J.C.3    Bieber, T.4    Lahfa, M.5    Rubins, A.6
  • 14
    • 12444288511 scopus 로고    scopus 로고
    • Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment
    • Carroll CL, Clarke J, Camacho F, Balkrishnan R, Feldman SR. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol 2005;141(1):43-46.
    • (2005) Arch Dermatol , vol.141 , Issue.1 , pp. 43-46
    • Carroll, C.L.1    Clarke, J.2    Camacho, F.3    Balkrishnan, R.4    Feldman, S.R.5
  • 16
    • 33947157611 scopus 로고    scopus 로고
    • A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis
    • Saraswat A, Agarwal R, Katare OP, Kaur I, Kumar B. A randomized, double-blind, vehicle-controlled study of a novel liposomal dithranol formulation in psoriasis. J Dermatol Treat 2007;18:40-45.
    • (2007) J Dermatol Treat , vol.18 , pp. 40-45
    • Saraswat, A.1    Agarwal, R.2    Katare, O.P.3    Kaur, I.4    Kumar, B.5
  • 17
    • 0031669579 scopus 로고    scopus 로고
    • Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): A new approach in the treatment of psoriasis
    • Gerritsen MJ, Boezeman JB, Elbers ME, van de Kerkhof PC. Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): a new approach in the treatment of psoriasis. Skin Pharmacol Appl Skin Physiol 1998;11(3):133-139.
    • (1998) Skin Pharmacol Appl Skin Physiol , vol.11 , Issue.3 , pp. 133-139
    • Gerritsen, M.J.1    Boezeman, J.B.2    Elbers, M.E.3    van de Kerkhof, P.C.4
  • 19
    • 0026444325 scopus 로고
    • Shortand long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis
    • Thune P and Brolund L. Shortand long-contact therapy using a new dithranol formulation in individually adjusted dosages in the management of psoriasis. Acta Derm Venereol Suppl (Stockh) 1992;172:28-29.
    • (1992) Acta Derm Venereol Suppl (Stockh) , vol.172 , pp. 28-29
    • Thune, P.1    Brolund, L.2
  • 20
    • 0024154170 scopus 로고
    • The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams
    • De Mare S, Calis N, den Hartog G, van Erp PE, van de Kerkhof PC. The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams. Skin Pharmacol 1988;1(4):259-264.
    • (1988) Skin Pharmacol , vol.1 , Issue.4 , pp. 259-264
    • de Mare, S.1    Calis, N.2    den Hartog, G.3    van Erp, P.E.4    van de Kerkhof, P.C.5
  • 22
    • 0033762738 scopus 로고    scopus 로고
    • The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis:A comparison with short-contact dithranol
    • Hutchinson PE, Marks R, White J. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis:a comparison with short-contact dithranol. Dermatology 2000;201(2):139-145.
    • (2000) Dermatology , vol.201 , Issue.2 , pp. 139-145
    • Hutchinson, P.E.1    Marks, R.2    White, J.3
  • 23
    • 0025278122 scopus 로고
    • The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis
    • Mahrle G and Schulze HJ. The effect of initial external glucocorticoid administration on cignolin treatment of psoriasis. Z Hautkr 1990;65(3):285-287.
    • (1990) Z Hautkr , vol.65 , Issue.3 , pp. 285-287
    • Mahrle, G.1    Schulze, H.J.2
  • 24
    • 0036235442 scopus 로고    scopus 로고
    • Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid
    • Swinkels OQ, Prins M, Kucharekova M, de Boo T, Gerritsen MJ, van der Valk PG, et al. Combining lesional short-contact dithranol therapy of psoriasis with a potent topical corticosteroid. Br J Dermatol 2002;146(4):621-626.
    • (2002) Br J Dermatol , vol.146 , Issue.4 , pp. 621-626
    • Swinkels, O.Q.1    Prins, M.2    Kucharekova, M.3    de Boo, T.4    Gerritsen, M.J.5    van der Valk, P.G.6
  • 25
    • 18444386181 scopus 로고    scopus 로고
    • Safety and efficacy of combined highdose treatment with calcipotriol ointment and solution in patients with psoriasis
    • van de Kerkhof PC, Green C, Hamberg KJ, Hutchinson PE, Jensen JK, Kidson P, et al. Safety and efficacy of combined highdose treatment with calcipotriol ointment and solution in patients with psoriasis. Dermatology 2002;204(3):214-221.
    • (2002) Dermatology , vol.204 , Issue.3 , pp. 214-221
    • van de Kerkhof, P.C.1    Green, C.2    Hamberg, K.J.3    Hutchinson, P.E.4    Jensen, J.K.5    Kidson, P.6
  • 26
    • 0022272876 scopus 로고
    • A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis
    • Agrup G and Agdell J. A comparison between Antraderm stick (0.5% and 1%) and dithranol paste (0.125% and 0.25%) in the treatment of psoriasis. Br J Clin Pract. 1985;39(5):185-187.
    • (1985) Br J Clin Pract , vol.39 , Issue.5 , pp. 185-187
    • Agrup, G.1    Agdell, J.2
  • 27
    • 38349098952 scopus 로고    scopus 로고
    • A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy:Quality-of life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting
    • Korte de J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, et al. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy:quality-of life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting. Br J Dermatol 2008;158:375-381.
    • (2008) Br J Dermatol , vol.158 , pp. 375-381
    • de Korte, J.1    van der Valk, P.G.2    Sprangers, M.A.3    Damstra, R.J.4    Kunkeler, A.C.5    Lijnen, R.L.6
  • 28
    • 2942566003 scopus 로고    scopus 로고
    • Effectiveness and side effects of UVBphototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis
    • Swinkels OQ, Prins M, Veenhuis RT, De Boo T, Gerritsen MJ, Van Der Wilt GJ, et al. Effectiveness and side effects of UVBphototherapy, dithranol inpatient therapy and a care instruction programme of short contact dithranol in moderate to severe psoriasis. Eur J Dermatol. 2004;14(3):159-165.
    • (2004) Eur J Dermatol , vol.14 , Issue.3 , pp. 159-165
    • Swinkels, O.Q.1    Prins, M.2    Veenhuis, R.T.3    de Boo, T.4    Gerritsen, M.J.5    van der Wilt, G.J.6
  • 29
    • 33748452857 scopus 로고    scopus 로고
    • A comparison of twicedaily calcipotriol ointment with once-daily short-contact dithranol cream therapy: A randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting
    • Oct
    • van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, et al. A comparison of twicedaily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting. Br J Dermatol 2006 Oct;155(4):800-807.
    • (2006) Br J Dermatol , vol.155 , Issue.4 , pp. 800-807
    • van de Kerkhof, P.C.1    van der Valk, P.G.2    Swinkels, O.Q.3    Kucharekova, M.4    de Rie, M.A.5    de Vries, H.J.6
  • 30
    • 0036667274 scopus 로고    scopus 로고
    • A novel liposomal formulation of dithranol for psoriasis:Preliminary results
    • Agarwal R, Saraswat A, Kaur I, Katare OP, Kumar B. A novel liposomal formulation of dithranol for psoriasis:preliminary results. J Dermatol. 2002;29(8):529-532.
    • (2002) J Dermatol , vol.29 , Issue.8 , pp. 529-532
    • Agarwal, R.1    Saraswat, A.2    Kaur, I.3    Katare, O.P.4    Kumar, B.5
  • 31
    • 0037231470 scopus 로고    scopus 로고
    • Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis
    • Papp KA, Guenther L, Boyden B, Larsen FG, Harvima RJ, Guilhou JJ, et al. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003;48(1):48-54
    • (2003) J Am Acad Dermatol , vol.48 , Issue.1 , pp. 48-54
    • Papp, K.A.1    Guenther, L.2    Boyden, B.3    Larsen, F.G.4    Harvima, R.J.5    Guilhou, J.J.6
  • 32
    • 0035986573 scopus 로고    scopus 로고
    • A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris
    • Douglas WS, Poulin Y, Decroix J, Ortonne JP, Mrowietz U, Gulliver W, et al. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm Venereol 2002;82(2):131-135.
    • (2002) Acta Derm Venereol , vol.82 , Issue.2 , pp. 131-135
    • Douglas, W.S.1    Poulin, Y.2    Decroix, J.3    Ortonne, J.P.4    Mrowietz, U.5    Gulliver, W.6
  • 33
    • 18744389433 scopus 로고    scopus 로고
    • A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris
    • Kaufmann R, Bibby AJ, Bissonnette R, Cambazard F, Chu AC, Decroix J,et al. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002;205(4):389-393.
    • (2002) Dermatology , vol.205 , Issue.4 , pp. 389-393
    • Kaufmann, R.1    Bibby, A.J.2    Bissonnette, R.3    Cambazard, F.4    Chu, A.C.5    Decroix, J.6
  • 34
    • 0023950227 scopus 로고
    • Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry
    • Weston WL, Fennessey PV, Morelli J, Schwab H, Mooney J, Samson C, et al. Comparison of hypothalamus-pituitary-adrenal axis suppression from superpotent topical steroids by standard endocrine function testing and gas chromatographic mass spectrometry. J Invest Dermatol 1988;90(4):532-535.
    • (1988) J Invest Dermatol , vol.90 , Issue.4 , pp. 532-535
    • Weston, W.L.1    Fennessey, P.V.2    Morelli, J.3    Schwab, H.4    Mooney, J.5    Samson, C.6
  • 35
    • 0024207134 scopus 로고
    • Management of psoriasis: A clinical evaluation of the dermatological patch, Actiderm®, over a topical steroid
    • Bagatell F. Management of psoriasis: A clinical evaluation of the dermatological patch, Actiderm®, over a topical steroid. Adv Ther. 1988;5(6):291-296.
    • (1988) Adv Ther , vol.5 , Issue.6 , pp. 291-296
    • Bagatell, F.1
  • 36
    • 0038163576 scopus 로고    scopus 로고
    • The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions
    • Gottlieb AB, Ford R, Spellman MC. The Efficacy and Tolerability of Clobetasol Propionate Foam 0.05% in the Treatment of Mild to Moderate Plaque-type Psoriasis of Nonscalp Regions. J Cutan Med Surg 2003;7(3):185-192.
    • (2003) J Cutan Med Surg , vol.7 , Issue.3 , pp. 185-192
    • Gottlieb, A.B.1    Ford, R.2    Spellman, M.C.3
  • 37
    • 25444469167 scopus 로고    scopus 로고
    • Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis
    • Aug
    • Lowe N, Feldman SR, Sherer D, Weiss J, Shavin JS, Lin YL, et al. Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat 2005 Aug;16(3):158-164.
    • (2005) J Dermatolog Treat , vol.16 , Issue.3 , pp. 158-164
    • Lowe, N.1    Feldman, S.R.2    Sherer, D.3    Weiss, J.4    Shavin, J.S.5    Lin, Y.L.6
  • 38
    • 4944234454 scopus 로고    scopus 로고
    • Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis
    • Decroix J, Pres H, Tsankov N, Poncet M, Arsonnaud S. Clobetasol propionate lotion in the treatment of moderate to severe plaque-type psoriasis. Cutis 2004;74(3):201-206.
    • (2004) Cutis , vol.74 , Issue.3 , pp. 201-206
    • Decroix, J.1    Pres, H.2    Tsankov, N.3    Poncet, M.4    Arsonnaud, S.5
  • 39
    • 0036062441 scopus 로고    scopus 로고
    • A randomized, doubleblind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis
    • Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, et al. A randomized, doubleblind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 2002;41(5):269-274.
    • (2002) Int J Dermatol , vol.41 , Issue.5 , pp. 269-274
    • Lebwohl, M.1    Sherer, D.2    Washenik, K.3    Krueger, G.G.4    Menter, A.5    Koo, J.6
  • 40
    • 70349250336 scopus 로고    scopus 로고
    • The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream:A Scholtz-Dumas bioassay comparison
    • Lee CS, Koo J. The efficacy of three class I topical synthetic corticosteroids, fluocinonide 0.1% cream, clobetasol 0.05% cream and halobetasol 0.05% cream:a Scholtz-Dumas bioassay comparison. Journal of drugs in dermatology:JDD 2009;8:751-755.
    • (2009) Journal of Drugs In Dermatology: JDD , vol.8 , pp. 751-755
    • Lee, C.S.1    Koo, J.2
  • 41
    • 34248999760 scopus 로고    scopus 로고
    • Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis
    • Mazzotta A, Esposito M, Carboni I, Schipani C, Chimenti S. Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. J Dermatolog Treat 2007;18(2):84-87.
    • (2007) J Dermatolog Treat , vol.18 , Issue.2 , pp. 84-87
    • Mazzotta, A.1    Esposito, M.2    Carboni, I.3    Schipani, C.4    Chimenti, S.5
  • 42
    • 35848943686 scopus 로고    scopus 로고
    • A comparative study of tar and betamethasone valerate in chronic plaque psoriasis:A study in Thailand
    • Thawornchaisit P, Harncharoen K. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis:a study in Thailand. J Med Assoc Thai 2007 Oct;90(10):1997-2002.
    • (2007) J Med Assoc Thai , vol.90 , Issue.10 , pp. 1997-2002
    • Thawornchaisit, P.1    Harncharoen, K.2
  • 43
    • 79751522327 scopus 로고    scopus 로고
    • LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone
    • Apr
    • Bagel J. LCD plus NB-UVB reduces time to improvement of psoriasis vs. NB-UVB alone. J Drugs Dermatol. 2009 Apr;8(4):351-357.
    • (2009) J Drugs Dermatol , vol.8 , Issue.4 , pp. 351-357
    • Bagel, J.1
  • 44
    • 0020034807 scopus 로고
    • The role of tar in Goeckerman therapy
    • Belsito DV and Kechijian P. The role of tar in Goeckerman therapy. Arch Dermatol. 1982;118(5):319-321.
    • (1982) Arch Dermatol , vol.118 , Issue.5 , pp. 319-321
    • Belsito, D.V.1    Kechijian, P.2
  • 45
    • 0018646940 scopus 로고
    • Tar gel-phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation
    • Frost P, Horwitz SN, Caputo RV, Berger SM. Tar gel-phototherapy for psoriasis. Combined therapy with suberythemogenic doses of fluorescent sunlamp ultraviolet radiation. Arch Dermatol 1979;115(7):840-846.
    • (1979) Arch Dermatol , vol.115 , Issue.7 , pp. 840-846
    • Frost, P.1    Horwitz, S.N.2    Caputo, R.V.3    Berger, S.M.4
  • 46
    • 0037258003 scopus 로고    scopus 로고
    • Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy
    • Camarasa JM, Ortonne JP, Dubertret L. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy. J Dermatolog Treat. 2003;14(1):8-13.
    • (2003) J Dermatolog Treat , vol.14 , Issue.1 , pp. 8-13
    • Camarasa, J.M.1    Ortonne, J.P.2    Dubertret, L.3
  • 47
    • 3142671892 scopus 로고    scopus 로고
    • Efficacy of once daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris
    • Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, et al. Efficacy of once daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004;150(6):1167-1173.
    • (2004) Br J Dermatol , vol.150 , Issue.6 , pp. 1167-1173
    • Kragballe, K.1    Noerrelund, K.L.2    Lui, H.3    Ortonne, J.P.4    Wozel, G.5    Uurasmaa, T.6
  • 48
    • 33947387857 scopus 로고    scopus 로고
    • An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis
    • Apr
    • Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, et al. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. J Eur Acad Dermatol Venereol 2007 Apr;21(4):466-472.
    • (2007) J Eur Acad Dermatol Venereol , vol.21 , Issue.4 , pp. 466-472
    • Zhu, X.1    Wang, B.2    Zhao, G.3    Gu, J.4    Chen, Z.5    Briantais, P.6
  • 49
    • 0033746053 scopus 로고    scopus 로고
    • A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis
    • Guenther LC, Poulin YP, Pariser DM. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis. Clin Ther 2000;22(10):1225-1238.
    • (2000) Clin Ther , vol.22 , Issue.10 , pp. 1225-1238
    • Guenther, L.C.1    Poulin, Y.P.2    Pariser, D.M.3
  • 50
    • 62449167557 scopus 로고    scopus 로고
    • A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis
    • Tabolli S, Alessandroni L, Didona B, Di PC, Gisondi P, Rota L, et al. A randomized controlled trial to evaluate short-term treatment with eosin vs. topical steroids in psoriasis. Clin Exp Dermatol 2009;34:304-308.
    • (2009) Clin Exp Dermatol , vol.34 , pp. 304-308
    • Tabolli, S.1    Alessandroni, L.2    Didona, B.3    Di, P.C.4    Gisondi, P.5    Rota, L.6
  • 51
    • 0036380889 scopus 로고    scopus 로고
    • Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris:A randomized, double-blind, vehicle-controlled clinical trial
    • Guenther L, van de Kerkhof PC, Snellman E, Kragballe K, Chu AC, Tegner E, et al. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris:a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002;147(2):316-323.
    • (2002) Br J Dermatol , vol.147 , Issue.2 , pp. 316-323
    • Guenther, L.1    van de Kerkhof, P.C.2    Snellman, E.3    Kragballe, K.4    Chu, A.C.5    Tegner, E.6
  • 52
    • 8344263988 scopus 로고    scopus 로고
    • Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris:A randomised, double-blind trial
    • Ortonne JP, Kaufmann R, Lecha M, Goodfield M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris:a randomised, double-blind trial. Dermatology 2004;209(4):308-313.
    • (2004) Dermatology , vol.209 , Issue.4 , pp. 308-313
    • Ortonne, J.P.1    Kaufmann, R.2    Lecha, M.3    Goodfield, M.4
  • 53
    • 33751532623 scopus 로고    scopus 로고
    • Efficacy results of a 52-week, randomised, doubleblind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris
    • Kragballe K, Austad J, Barnes L, Bibby A, de-la BM, Cambazard F, et al. Efficacy results of a 52-week, randomised, doubleblind, safety study of a calcipotriol/betamethasone dipropionate two-compound product (Daivobet/Dovobet/Taclonex) in the treatment of psoriasis vulgaris. Dermatology 2006;213:319-326.
    • (2006) Dermatology , vol.213 , pp. 319-326
    • Kragballe, K.1    Austad, J.2    Barnes, L.3    Bibby, A.4    De-La, B.M.5    Cambazard, F.6
  • 54
    • 23844532011 scopus 로고    scopus 로고
    • Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris
    • Peeters P, Ortonne JP, Sitbon R, Guignard E. Cost-effectiveness of once-daily treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol in the treatment of Psoriasis vulgaris. Dermatology 2005;211:139-145.
    • (2005) Dermatology , vol.211 , pp. 139-145
    • Peeters, P.1    Ortonne, J.P.2    Sitbon, R.3    Guignard, E.4
  • 55
    • 36849008096 scopus 로고    scopus 로고
    • Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris:A randomized, multicentre, clinical trial
    • Saraceno R, Andreassi L, Ayala F, Bongiorno MR, Giannetti A, Lisi P, et al. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris:a randomized, multicentre, clinical trial. J Dermatol Treat 2007;18:361-365.
    • (2007) J Dermatol Treat , vol.18 , pp. 361-365
    • Saraceno, R.1    Andreassi, L.2    Ayala, F.3    Bongiorno, M.R.4    Giannetti, A.5    Lisi, P.6
  • 58
  • 59
  • 60
    • 15144359977 scopus 로고    scopus 로고
    • Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B
    • Dec
    • Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997 Dec;133(12):1514-22.
    • (1997) Arch Dermatol , vol.133 , Issue.12 , pp. 1514-1522
    • Coven, T.R.1    Burack, L.H.2    Gilleaudeau, R.3    Keogh, M.4    Ozawa, M.5    Krueger, J.G.6
  • 61
    • 0018745701 scopus 로고
    • Oral retinoid and UVB radiation: A new, alternative treatment for psoriasis on an out-patient basis
    • Orfanos CE, Steigleder GK, Pullmann H, Bloch PH. Oral retinoid and UVB radiation: a new, alternative treatment for psoriasis on an out-patient basis. Acta Derm Venereol. 1979;59(3):241-4.
    • (1979) Acta Derm Venereol , vol.59 , Issue.3 , pp. 241-244
    • Orfanos, C.E.1    Steigleder, G.K.2    Pullmann, H.3    Bloch, P.H.4
  • 62
    • 0020696185 scopus 로고
    • Topical steroids and UV radiation in psoriasis
    • Mar
    • Petrozzi JW. Topical steroids and UV radiation in psoriasis. Arch Dermatol. 1983 Mar;119(3):207-10.
    • (1983) Arch Dermatol , vol.119 , Issue.3 , pp. 207-210
    • Petrozzi, J.W.1
  • 63
    • 0033967598 scopus 로고    scopus 로고
    • Calcipotriol cream combined with twice weekly broadband UVB phototherapy: A safe, effective and UVB-sparing antipsoriatric combination treatment
    • The Canadian Calcipotriol and UVB Study Group
    • Ramsay CA, Schwartz BE, Lowson D, Papp K, Bolduc A, Gilbert M. Calcipotriol cream combined with twice weekly broadband UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. Dermatology. 2000;200(1):17-24.
    • (2000) Dermatology , vol.200 , Issue.1 , pp. 17-24
    • Ramsay, C.A.1    Schwartz, B.E.2    Lowson, D.3    Papp, K.4    Bolduc, A.5    Gilbert, M.6
  • 64
    • 0034797986 scopus 로고    scopus 로고
    • Comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths
    • Aug
    • Arnold WP, van Andel P, de Hoop D, de Jong-Tieben L, Visser-van Andel MA. Comparison of the effect of narrow-band ultraviolet B in the treatment of psoriasis after salt-water baths and after 8-methoxypsoralen baths. Br J Dermatol. 2001 Aug;145(2):352-4.
    • (2001) Br J Dermatol , vol.145 , Issue.2 , pp. 352-354
    • Arnold, W.P.1    van Andel, P.2    de Hoop, D.3    de Jong-Tieben, L.4    Visser-Van andel, M.A.5
  • 65
    • 0032695610 scopus 로고    scopus 로고
    • A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis
    • Nov
    • Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol. 1999 Nov; 41(5 Pt 1):728-32.
    • (1999) J Am Acad Dermatol , vol.41 , Issue.5 PART 1 , pp. 728-732
    • Gordon, P.M.1    Diffey, B.L.2    Matthews, J.N.3    Farr, P.M.4
  • 66
    • 0037342633 scopus 로고    scopus 로고
    • Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis
    • Mar
    • Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol. 2003 Mar;139(3):325-8.
    • (2003) Arch Dermatol , vol.139 , Issue.3 , pp. 325-328
    • Markham, T.1    Rogers, S.2    Collins, P.3
  • 69
    • 0033818235 scopus 로고    scopus 로고
    • Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis
    • Oct
    • Leenutaphong V, Nimkulrat P, Sudtim S. Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis. Photodermatol Photoimmunol Photomed. 2000 Oct;16(5):202-6.
    • (2000) Photodermatol Photoimmunol Photomed , vol.16 , Issue.5 , pp. 202-206
    • Leenutaphong, V.1    Nimkulrat, P.2    Sudtim, S.3
  • 70
    • 67650085602 scopus 로고    scopus 로고
    • Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: Pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study)
    • Koek MB, Buskens E, van Weelden H, Steegmans PH, Bruijnzeel-Koomen CA, Sigurdsson V. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study). BMJ 2009;338:b1542.
    • (2009) BMJ , vol.338
    • Koek, M.B.1    Buskens, E.2    van Weelden, H.3    Steegmans, P.H.4    Bruijnzeel-Koomen, C.A.5    Sigurdsson, V.6
  • 71
    • 0036438882 scopus 로고    scopus 로고
    • Taking treatment to the patient: Development of a home TL-01 ultraviolet B phototherapy service
    • Cameron HY. Taking treatment to the patient: Development of a home TL-01 ultraviolet B phototherapy service. Br J Dermatol. 2002;147(5):957-65.
    • (2002) Br J Dermatol , vol.147 , Issue.5 , pp. 957-965
    • Cameron, H.Y.1
  • 72
    • 0026719150 scopus 로고
    • The effect of flash lamp-pulsed dye laser on psoriasis
    • Jun
    • Hacker SM, Rasmussen JE. The effect of flash lamp-pulsed dye laser on psoriasis. Arch Dermatol. 1992 Jun;128(6):853-5.
    • (1992) Arch Dermatol , vol.128 , Issue.6 , pp. 853-855
    • Hacker, S.M.1    Rasmussen, J.E.2
  • 73
    • 27544441213 scopus 로고    scopus 로고
    • Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis
    • Nov
    • Taibjee SM, Cheung ST, Laube S, Lanigan SW. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis. Br J Dermatol. 2005 Nov;153(5):960-6.
    • (2005) Br J Dermatol , vol.153 , Issue.5 , pp. 960-966
    • Taibjee, S.M.1    Cheung, S.T.2    Laube, S.3    Lanigan, S.W.4
  • 74
    • 0036828012 scopus 로고    scopus 로고
    • Medium-dose 308-nm excimer laser for the treatment of psoriasis
    • Nov
    • Trehan M, Taylor CR. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002 Nov;47(5):701-8.
    • (2002) J Am Acad Dermatol , vol.47 , Issue.5 , pp. 701-708
    • Trehan, M.1    Taylor, C.R.2
  • 75
    • 33747035014 scopus 로고    scopus 로고
    • Excimer laser versus narrowband UVB (311 nm) in the treatment of psoriasis vulgaris
    • Goldinger SM, Dummer R, Schmid P, Vavricka MP, Burg G, Lauchli S. Excimer laser versus narrowband UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology. 2006;213(2):134-139.
    • (2006) Dermatology , vol.213 , Issue.2 , pp. 134-139
    • Goldinger, S.M.1    Dummer, R.2    Schmid, P.3    Vavricka, M.P.4    Burg, G.5    Lauchli, S.6
  • 78
    • 17644393510 scopus 로고    scopus 로고
    • Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis
    • Apr
    • Kollner K, Wimmershoff MB, Hintz C, Landthaler M, Hohenleutner U. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis. Br J Dermatol. 2005 Apr;152(4):750-4.
    • (2005) Br J Dermatol , vol.152 , Issue.4 , pp. 750-754
    • Kollner, K.1    Wimmershoff, M.B.2    Hintz, C.3    Landthaler, M.4    Hohenleutner, U.5
  • 79
    • 33746073770 scopus 로고    scopus 로고
    • Randomized double-blind trial of the treatment of chronic plaque psoriasis: Efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy
    • Yones SS, Palmer RA, Garibaldinos TT, Hawk JLM. Randomized double-blind trial of the treatment of chronic plaque psoriasis: Efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy. Arch Dermatol. 2006;142(7):836-842.
    • (2006) Arch Dermatol , vol.142 , Issue.7 , pp. 836-842
    • Yones, S.S.1    Palmer, R.A.2    Garibaldinos, T.T.3    Hawk, J.L.M.4
  • 80
    • 0036884653 scopus 로고    scopus 로고
    • Management of guttate and generalized psoriasis vulgaris: Prospective randomized study
    • Dec
    • Caca-Biljanovska NG, V'Lckova-Laskoska MT. Management of guttate and generalized psoriasis vulgaris: prospective randomized study. Croat Med J. 2002 Dec;43(6):707-12.
    • (2002) Croat Med J , vol.43 , Issue.6 , pp. 707-712
    • Caca-Biljanovska, N.G.1    V'Lckova-Laskoska, M.T.2
  • 81
    • 0018102879 scopus 로고
    • Photochemotherapy by 8-methoxypsoralen and UVA in psoriasis vulgaris-clinical experiences in 5 dermatological departments of GDR (author's transl)
    • Jun
    • Barth J, Dietz O, Heilmann S, Kadner H, Kraensel H, Meffert H, et al. Photochemotherapy by 8-methoxypsoralen and UVA in psoriasis vulgaris-clinical experiences in 5 dermatological departments of GDR (author's transl). Dermatol Monatsschr. 1978 Jun;164(6):401-7.
    • (1978) Dermatol Monatsschr , vol.164 , Issue.6 , pp. 401-407
    • Barth, J.1    Dietz, O.2    Heilmann, S.3    Kadner, H.4    Kraensel, H.5    Meffert, H.6
  • 82
    • 0028053469 scopus 로고
    • Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen
    • Oct
    • Berg M, Ros AM. Treatment of psoriasis with psoralens and ultraviolet A. A double-blind comparison of 8-methoxypsoralen and 5-methoxypsoralen. Photodermatol Photoimmunol Photomed. 1994 Oct;10 (5):217-20.
    • (1994) Photodermatol Photoimmunol Photomed , vol.10 , Issue.5 , pp. 217-220
    • Berg, M.1    Ros, A.M.2
  • 83
    • 0029156956 scopus 로고
    • Comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis
    • Sep
    • Buckley DA, Healy E, Rogers SA. Comparison of twice-weekly MPD-PUVA and three times-weekly skin typing-PUVA regimens for the treatment of psoriasis. Br J Dermatol. 1995 Sep;133(3):417-22.
    • (1995) Br J Dermatol , vol.133 , Issue.3 , pp. 417-422
    • Buckley, D.A.1    Healy, E.2    Rogers, S.A.3
  • 85
    • 0026655964 scopus 로고
    • Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis
    • Oct
    • Collins P, Rogers S. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol. 1992 Oct;127(4):392-5.
    • (1992) Br J Dermatol , vol.127 , Issue.4 , pp. 392-395
    • Collins, P.1    Rogers, S.2
  • 86
    • 0033994781 scopus 로고    scopus 로고
    • A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis
    • Mar
    • Cooper EJ, Herd RM, Priestley GC, Hunter JA. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol. 2000 Mar;25(2):111-4.
    • (2000) Clin Exp Dermatol , vol.25 , Issue.2 , pp. 111-114
    • Cooper, E.J.1    Herd, R.M.2    Priestley, G.C.3    Hunter, J.A.4
  • 87
    • 84943440540 scopus 로고
    • Psoralens and UVA and UV-B twice weekly for the treatment of psoriasis
    • Sep
    • Diette KM, Momtaz TK, Stern RS, Arndt KA, Parrish JA. Psoralens and UVA and UV-B twice weekly for the treatment of psoriasis. Arch Dermatol. 1984 Sep;120(9):1169-73.
    • (1984) Arch Dermatol , vol.120 , Issue.9 , pp. 1169-1173
    • Diette, K.M.1    Momtaz, T.K.2    Stern, R.S.3    Arndt, K.A.4    Parrish, J.A.5
  • 88
    • 0018622793 scopus 로고
    • Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate
    • Sep
    • Hanke CW, Steck WD, Roenigk Jr. HH. Combination therapy for psoriasis. Psoralens plus long-wave ultraviolet radiation with betamethasone valerate. Arch Dermatol. 1979 Sep;115(9):1074-7.
    • (1979) Arch Dermatol , vol.115 , Issue.9 , pp. 1074-1077
    • Hanke, C.W.1    Steck, W.D.2    Roenigk, H.H.3
  • 89
    • 0034535068 scopus 로고    scopus 로고
    • Psoralenultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: Our experience with fitzpatrick skin type IV
    • Nov
    • Khurshid K, Haroon TS, Hussain I, Pal SS, Jahangir M, Zaman T. Psoralenultraviolet A therapy vs. psoralen-ultraviolet B therapy in the treatment of plaque-type psoriasis: our experience with fitzpatrick skin type IV. Int J Dermatol. 2000 Nov;39(11):865-7.
    • (2000) Int J Dermatol , vol.39 , Issue.11 , pp. 865-867
    • Khurshid, K.1    Haroon, T.S.2    Hussain, I.3    Pal, S.S.4    Jahangir, M.5    Zaman, T.6
  • 90
    • 0032905022 scopus 로고    scopus 로고
    • Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis
    • Apr
    • Kirby B, Buckley DA, Rogers S. Large increments in psoralen-ultraviolet A (PUVA) therapy are unsuitable for fair-skinned individuals with psoriasis. Br J Dermatol. 1999 Apr;140 (4):661-6.
    • (1999) Br J Dermatol , vol.140 , Issue.4 , pp. 661-666
    • Kirby, B.1    Buckley, D.A.2    Rogers, S.3
  • 91
    • 0023952484 scopus 로고
    • Combination of photochemotherapy (PUVA) and ultraviolet B (UVB) in the treatment of psoriasis vulgaris
    • Feb
    • Park YK, Kim HJ, Koh YJ. Combination of photochemotherapy (PUVA) and ultraviolet B (UVB) in the treatment of psoriasis vulgaris. J Dermatol. 1988 Feb;15(1):68-71.
    • (1988) J Dermatol , vol.15 , Issue.1 , pp. 68-71
    • Park, Y.K.1    Kim, H.J.2    Koh, Y.J.3
  • 92
    • 0021343494 scopus 로고
    • A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis
    • Feb
    • Parker S, Coburn P, Lawrence C. Marks J, Shuster S. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis. Br J Dermatol. 1984 Feb;110(2):215-20.
    • (1984) Br J Dermatol , vol.110 , Issue.2 , pp. 215-220
    • Parker, S.1    Coburn, P.2    Lawrence, C.3    Marks, J.4    Shuster, S.5
  • 93
    • 0016385502 scopus 로고
    • Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light
    • Dec 5
    • Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light. N Engl J Med. 1974 Dec 5;291(23):1207-11.
    • (1974) N Engl J Med , vol.291 , Issue.23 , pp. 1207-1211
    • Parrish, J.A.1    Fitzpatrick, T.B.2    Tanenbaum, L.3    Pathak, M.A.4
  • 94
    • 0018755659 scopus 로고
    • Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis
    • Mar 3
    • Rogers S, Marks J, Shuster S, Vella Briffa DV, Warin A, Greaves M. Comparison of photochemotherapy and dithranol in the treatment of chronic plaque psoriasis. Lancet. 1979 Mar 3;1(8114):455-8.
    • (1979) Lancet , vol.1 , Issue.8114 , pp. 455-458
    • Rogers, S.1    Marks, J.2    Shuster, S.3    Vella, B.D.V.4    Warin, A.5    Greaves, M.6
  • 95
    • 0018156810 scopus 로고
    • A randomized, controlled clinical trial comparing photochemotherapy with dithranol in the initial treatment of chronic plaque psoriasis
    • Dec
    • Vella Briffa D, Rogers S, Greaves MW, Marks J, Shuster S, Warin AP. A randomized, controlled clinical trial comparing photochemotherapy with dithranol in the initial treatment of chronic plaque psoriasis. Clin Exp Dermatol. 1978 Dec;3(4):339-47.
    • (1978) Clin Exp Dermatol , vol.3 , Issue.4 , pp. 339-347
    • Vella, B.D.1    Rogers, S.2    Greaves, M.W.3    Marks, J.4    Shuster, S.5    Warin, A.P.6
  • 96
    • 38349032588 scopus 로고    scopus 로고
    • A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study)
    • El-Mofty M, El Weshahy H, Youssef R, Abdel-Halim M, Mashaly H, El Hawary M. A comparative study of different treatment frequencies of psoralen and ultraviolet A in psoriatic patients with darker skin types (randomized-controlled study). Photodermatology Photoimmunology and Photomedicine. 2008; 24(1):38-42.
    • (2008) Photodermatology Photoimmunology and Photomedicine , vol.24 , Issue.1 , pp. 38-42
    • El-Mofty, M.1    El-Weshahy, H.2    Youssef, R.3    Abdel-Halim, M.4    Mashaly, H.5    El-Hawary, M.6
  • 97
    • 0019522309 scopus 로고
    • Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: A cooperative study among 18 European centres
    • Henseler T, Wolff K, Honigsmann H, Christophers E. Oral 8-methoxypsoralen photochemotherapy of psoriasis. The European PUVA study: a cooperative study among 18 European centres. Lancet. 1981 Apr 18;1(8225):853-7.
    • (1981) Lancet , vol.1 , Issue.8225 , pp. 853-857
    • Henseler, T.1    Wolff, K.2    Honigsmann, H.3    Christophers, E.4
  • 98
    • 0023786883 scopus 로고
    • Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis
    • Saurat JH, Geiger JM, Amblard P, Beani JC, Boulanger A, Claudy A, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica. 1988;177(4):218-24.
    • (1988) Dermatologica , vol.177 , Issue.4 , pp. 218-224
    • Saurat, J.H.1    Geiger, J.M.2    Amblard, P.3    Beani, J.C.4    Boulanger, A.5    Claudy, A.6
  • 99
    • 0344885563 scopus 로고    scopus 로고
    • Efficacy of acitretin and commercial tanning bed therapy for psoriasis
    • Apr
    • Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol. 2003 Apr;139(4):436-42.
    • (2003) Arch Dermatol , vol.139 , Issue.4 , pp. 436-442
    • Carlin, C.S.1    Callis, K.P.2    Krueger, G.G.3
  • 100
    • 0024312928 scopus 로고
    • A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis
    • Jul
    • Lauharanta J, Geiger JM. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol. 1989 Jul;12 (1):107-12.
    • (1989) Br J Dermatol , vol.12 , Issue.1 , pp. 107-112
    • Lauharanta, J.1    Geiger, J.M.2
  • 101
    • 36849031709 scopus 로고    scopus 로고
    • Methotrexate vs ciclosporin in psoriasis: Effectiveness, quality of life and safety
    • Flytstrom I, Stenberg B, Svensson A, Bergbrant I-M. Methotrexate vs ciclosporin in psoriasis: effectiveness, quality of life and safety. Br J Dermatol 2008;158:116-121.
    • (2008) Br J Dermatol , vol.158 , pp. 116-121
    • Flytstrom, I.1    Stenberg, B.2    Svensson, A.3    Bergbrant, I.-M.4
  • 102
    • 35148882152 scopus 로고    scopus 로고
    • Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis:A comparative study
    • Ranjan N, Sharma NL, Shanker V, Mahajan VK, Tegta GR. Methotrexate versus hydroxycarbamide (hydroxyurea) as a weekly dose to treat moderate-to-severe chronic plaque psoriasis:a comparative study. J Dermatol Treat 2007;18(5):295-300.
    • (2007) J Dermatol Treat , vol.18 , Issue.5 , pp. 295-300
    • Ranjan, N.1    Sharma, N.L.2    Shanker, V.3    Mahajan, V.K.4    Tegta, G.R.5
  • 103
    • 39049143819 scopus 로고    scopus 로고
    • Efficacy and safety results from the randomized controled comparative study of adalimumab vs methotrexate vs placebo in patients with psoriasis (CHAMPION)
    • Saurat JH, Stingl G, Dubertret L, Papp K, Langley RG, Ortonne JP, et al. Efficacy and safety results from the randomized controled comparative study of adalimumab vs methotrexate vs placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008;158:558-566.
    • (2008) Br J Dermatol , vol.158 , pp. 558-566
    • Saurat, J.H.1    Stingl, G.2    Dubertret, L.3    Papp, K.4    Langley, R.G.5    Ortonne, J.P.6
  • 105
    • 78449293438 scopus 로고    scopus 로고
    • Efficacy and safety of mycophenolate mofetil vs methotrexate for the treatment of chronic plaque psoriasis
    • Dec
    • Akhyani M, Chams-Davatchi C, Hemami MR, Fateh S. Efficacy and safety of mycophenolate mofetil vs methotrexate for the treatment of chronic plaque psoriasis. J Eur Acad Dermatol Venereol 2010 Dec;24(12):1447-1451.
    • (2010) J Eur Acad Dermatol Venereol , vol.24 , Issue.12 , pp. 1447-1451
    • Akhyani, M.1    Chams-Davatchi, C.2    Hemami, M.R.3    Fateh, S.4
  • 106
    • 55849143623 scopus 로고    scopus 로고
    • Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy; a randomized, controlled, investigator-blinded clinical trial
    • Gisondi P, Del Giglio M, Di Francesco V, Zamboni M, Girolomoni G. Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy; a randomized, controlled, investigator-blinded clinical trial. Am J Clin Nutr. 2008;88:1242-1247.
    • (2008) Am J Clin Nutr , vol.88 , pp. 1242-1247
    • Gisondi, P.1    Del Giglio, M.2    Di Francesco, V.3    Zamboni, M.4    Girolomoni, G.5
  • 107
    • 0031847245 scopus 로고    scopus 로고
    • A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group
    • Koo J. A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral and Sandimmun, in patients with severe psoriasis. OLP302 Study Group. Br J Dermatol. 1998;139:88-95.
    • (1998) Br J Dermatol , vol.139 , pp. 88-95
    • Koo, J.1
  • 109
    • 0036062778 scopus 로고    scopus 로고
    • Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998
    • author reply 185-186
    • Nijsten TE, Stern RS. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998. Br J Dermatol. 2002;147:184-5; author reply 185-186.
    • (2002) Br J Dermatol , vol.147 , pp. 184-185
    • Nijsten, T.E.1    Stern, R.S.2
  • 110
    • 20344385553 scopus 로고    scopus 로고
    • Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity
    • Yuan J, Zhou J, Chen BC, Zhang X, Zhou HM, Du DF, et al. Magnesium supplementation prevents chronic cyclosporine nephrotoxicity via adjusting nitric oxide synthase activity. Transplant Proc. 2005;37:1892-1895.
    • (2005) Transplant Proc , vol.37 , pp. 1892-1895
    • Yuan, J.1    Zhou, J.2    Chen, B.C.3    Zhang, X.4    Zhou, H.M.5    Du, D.F.6
  • 111
    • 0024531946 scopus 로고
    • A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study
    • Kragballe K, Jansen CT, Geiger JM, Bjerke JR, Falk ES, Gip L, et al. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study. Acta Derm Venereol. 1989;69(1):35-40.
    • (1989) Acta Derm Venereol , vol.69 , Issue.1 , pp. 35-40
    • Kragballe, K.1    Jansen, C.T.2    Geiger, J.M.3    Bjerke, J.R.4    Falk, E.S.5    Gip, L.6
  • 113
    • 6844260549 scopus 로고    scopus 로고
    • The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis
    • Jan
    • van de Kerkhof PC, Cambazard F, Hutchinson PE, Haneke E, Wong E, Souteyrand P, et al. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br J Dermatol. 1998 Jan;138(1):84-89.
    • (1998) Br J Dermatol , vol.138 , Issue.1 , pp. 84-89
    • van de Kerkhof, P.C.1    Cambazard, F.2    Hutchinson, P.E.3    Haneke, E.4    Wong, E.5    Souteyrand, P.6
  • 115
    • 20244383720 scopus 로고
    • Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients
    • Jun
    • Altmeyer PJ, Matthes U, Pawlak F, Hoffmann K, Frosch PJ, Ruppert P, et al. Antipsoriatic effect of fumaric acid derivatives. Results of a multicenter double-blind study in 100 patients. J Am Acad Dermatol. 1994 Jun;30(6):977-981.
    • (1994) J Am Acad Dermatol , vol.30 , Issue.6 , pp. 977-981
    • Altmeyer, P.J.1    Matthes, U.2    Pawlak, F.3    Hoffmann, K.4    Frosch, P.J.5    Ruppert, P.6
  • 116
    • 0036978134 scopus 로고    scopus 로고
    • Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris
    • Gollnick H, Altmeyer P, Kaufmann R, Ring J, Christophers E, Pavel S, et al. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology. 2002;205(1):46-53.
    • (2002) Dermatology , vol.205 , Issue.1 , pp. 46-53
    • Gollnick, H.1    Altmeyer, P.2    Kaufmann, R.3    Ring, J.4    Christophers, E.5    Pavel, S.6
  • 118
    • 0026737371 scopus 로고
    • Fumaric acid therapy in psoriasis: Results and side effects of 2 years of treatment
    • Nov
    • Kolbach DN, Nieboer C. Fumaric acid therapy in psoriasis: results and side effects of 2 years of treatment. J Am Acad Dermatol. 1992 Nov;27(5 Pt 1):769-771.
    • (1992) J Am Acad Dermatol , vol.27 , Issue.5 PART 1 , pp. 769-771
    • Kolbach, D.N.1    Nieboer, C.2
  • 119
    • 0025309310 scopus 로고
    • Fumaric acid therapy in psoriasis; A double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester
    • Nieboer C, Hoop D de, Langendijk PNJ, Loenen AC van, Gubbels J. Fumaric acid therapy in psoriasis; A double-blind comparison between fumaric acid compound therapy and monotherapy with dimethylfumaric acid ester. Dermatologica 1990;181:22-27.
    • (1990) Dermatologica , vol.181 , pp. 22-27
    • Nieboer, C.1    De Hoop D2    Langendijk, P.N.J.3    Van Loenen, A.C.4    Gubbels, J.5
  • 120
    • 0029664707 scopus 로고    scopus 로고
    • Efficacy and safety profile of fumaric acid esters in oral longterm therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients
    • Altmeyer P, Hartwig R, Matthes U. Efficacy and safety profile of fumaric acid esters in oral longterm therapy with severe treatment refractory psoriasis vulgaris. A study of 83 patients. Hautarzt 1996;47:190-196.
    • (1996) Hautarzt , vol.47 , pp. 190-196
    • Altmeyer, P.1    Hartwig, R.2    Matthes, U.3
  • 121
    • 0023198020 scopus 로고
    • Peroral long-term treatment of psoriasis using fumaric acid derivatives
    • Bayard W, Hunziker T, Krebs A, Speiser P, Joshi R. Peroral long-term treatment of psoriasis using fumaric acid derivatives. Hautarzt 1987;38:279-285.
    • (1987) Hautarzt , vol.38 , pp. 279-285
    • Bayard, W.1    Hunziker, T.2    Krebs, A.3    Speiser, P.4    Joshi, R.5
  • 122
    • 0037364080 scopus 로고    scopus 로고
    • Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines
    • Litjens NH, Nibbering PH, Barrois AJ, Zomerdijk TP, van den Oudenrijn AC, Noz KC, et al. Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokines. Br J Dermatol 2003;148:444-451.
    • (2003) Br J Dermatol , vol.148 , pp. 444-451
    • Litjens, N.H.1    Nibbering, P.H.2    Barrois, A.J.3    Zomerdijk, T.P.4    van den Oudenrijn, A.C.5    Noz, K.C.6
  • 124
    • 0032858530 scopus 로고    scopus 로고
    • Treatment of severe psoriasis with fumaric acid esters: Scientific background and guidelines for therapeutic use
    • for the German Fumaric Acid Ester Consensus Conference
    • Mrowietz U, Christophers E, Altmeyer P, for the German Fumaric Acid Ester Consensus Conference. Treatment of severe psoriasis with fumaric acid esters: scientific background and guidelines for therapeutic use. Br J Dermatol 1999;141:424-429.
    • (1999) Br J Dermatol , vol.141 , pp. 424-429
    • Mrowietz, U.1    Christophers, E.2    Altmeyer, P.3
  • 125
    • 79951727038 scopus 로고    scopus 로고
    • Definition of treatment goals for moderate to severe psoriasis: An European consensus
    • Jan
    • Mrowietz U, Kragballe K, Reich K, Spuls P, Griffiths CE, Nast A, et al. Definition of treatment goals for moderate to severe psoriasis: an European consensus. Arch Dermatol Res. 2011 Jan;303(1):1-10.
    • (2011) Arch Dermatol Res , vol.303 , Issue.1 , pp. 1-10
    • Mrowietz, U.1    Kragballe, K.2    Reich, K.3    Spuls, P.4    Griffiths, C.E.5    Nast, A.6
  • 126
    • 70349323598 scopus 로고    scopus 로고
    • Experience with biologics for psoriasis in daily practice: Switching is worth a try
    • Lecluse LL, de Groot M, Bos JD, Spuls PI. Experience with biologics for psoriasis in daily practice: switching is worth a try. Br J Dermatol. 2009:161(4):948-951.
    • (2009) Br J Dermatol , vol.161 , Issue.4 , pp. 948-951
    • Lecluse, L.L.1    de Groot, M.2    Bos, J.D.3    Spuls, P.I.4
  • 127
    • 77957021919 scopus 로고    scopus 로고
    • Switching from etanercept to adalimumab is effective and safe: Results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept
    • Oct
    • van Lümig PP, Lecluse LL, Driessen RJ, Spuls PI, Boezeman JB, van de Kerkhof PC, et al. Switching from etanercept to adalimumab is effective and safe: results in 30 patients with psoriasis with primary failure, secondary failure or intolerance to etanercept. Br J Dermatol. 2010 Oct;163(4):838-846.
    • (2010) Br J Dermatol , vol.163 , Issue.4 , pp. 838-846
    • van Lümig, P.P.1    Lecluse, L.L.2    Driessen, R.J.3    Spuls, P.I.4    Boezeman, J.B.5    van de Kerkhof, P.C.6
  • 128
    • 0035968626 scopus 로고    scopus 로고
    • Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: Nested cohort crossover study
    • Sep 29
    • Marcil I, Stern RS. Squamous-cell cancer of the skin in patients given PUVA and ciclosporin: nested cohort crossover study. Lancet. 2001 Sep 29;358(9287):1042-1045.
    • (2001) Lancet , vol.358 , Issue.9287 , pp. 1042-1045
    • Marcil, I.1    Stern, R.S.2
  • 129
    • 0042905776 scopus 로고    scopus 로고
    • The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: A cohort study
    • Aug
    • Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol. 2003 Aug;121(2):252-258.
    • (2003) J Invest Dermatol , vol.121 , Issue.2 , pp. 252-258
    • Nijsten, T.E.1    Stern, R.S.2
  • 130
    • 15044361996 scopus 로고    scopus 로고
    • High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients
    • Mar
    • Lim JL, Stern RS. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients. J Invest Dermatol. 2005 Mar;124(3):505-513.
    • (2005) J Invest Dermatol , vol.124 , Issue.3 , pp. 505-513
    • Lim, J.L.1    Stern, R.S.2
  • 131
    • 70350041758 scopus 로고    scopus 로고
    • Cancer risk evaluation in psoriasis: In search of the Holy Grail?
    • Nov
    • Paul CF, Gourraud PA. Cancer risk evaluation in psoriasis: in search of the Holy Grail? J Invest Dermatol. 2009 Nov;129(11):2547-2549.
    • (2009) J Invest Dermatol , vol.129 , Issue.11 , pp. 2547-2549
    • Paul, C.F.1    Gourraud, P.A.2
  • 132
    • 43449139402 scopus 로고    scopus 로고
    • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, doubleblind, placebo-controlled trial (PHOENIX 2)
    • Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, doubleblind, placebo-controlled trial (PHOENIX 2). Lancet 2008; 371: 1675-1684.
    • (2008) Lancet , vol.371 , pp. 1675-1684
    • Papp, K.A.1    Langley, R.G.2    Lebwohl, M.3    Krueger, G.G.4    Szapary, P.5    Yeilding, N.6
  • 134
    • 80052074383 scopus 로고    scopus 로고
    • Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: A meta-analysis of randomized controlled trials
    • Aug 24
    • Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, et al. Association between biologic therapies for chronic plaque psoriasis and cardiovascular events: a meta-analysis of randomized controlled trials. JAMA. 2011 Aug 24;306(8):864-871.
    • (2011) JAMA , vol.306 , Issue.8 , pp. 864-871
    • Ryan, C.1    Leonardi, C.L.2    Krueger, J.G.3    Kimball, A.B.4    Strober, B.E.5    Gordon, K.B.6
  • 135
    • 77949571175 scopus 로고    scopus 로고
    • The risk of infections with biologic therapies for rheumatoid arthritis
    • Apr
    • Furst DE.The risk of infections with biologic therapies for rheumatoid arthritis. Semin Arthritis Rheum. 2010 Apr;39(5):327-346.
    • (2010) Semin Arthritis Rheum , vol.39 , Issue.5 , pp. 327-346
    • Furst, D.E.1
  • 136
    • 27444435655 scopus 로고    scopus 로고
    • Asthenoazoospermia in patients receiving antitumour necrosis factor {alpha} agents
    • Nov
    • Montagna GL, Malesci D, Buono R, Valentini G. Asthenoazoospermia in patients receiving antitumour necrosis factor {alpha} agents. Ann Rheum Dis. 2005 Nov;64(11):1667.
    • (2005) Ann Rheum Dis , vol.64 , Issue.11 , pp. 1667
    • Montagna, G.L.1    Malesci, D.2    Buono, R.3    Valentini, G.4
  • 137
  • 138
    • 64849094936 scopus 로고    scopus 로고
    • Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab
    • Feb
    • Paschou S, Voulgari PV, Vrabie IG, Saougou IG, Drosos AA. Fertility and reproduction in male patients with ankylosing spondylitis treated with infliximab. J Rheumatol. 2009 Feb;36(2):351-354.
    • (2009) J Rheumatol , vol.36 , Issue.2 , pp. 351-354
    • Paschou, S.1    Voulgari, P.V.2    Vrabie, I.G.3    Saougou, I.G.4    Drosos, A.A.5
  • 139
    • 0038384134 scopus 로고    scopus 로고
    • Placental transport of immunoglobulin G
    • Jul 28
    • Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003 Jul 28;21(24):3365-3369.
    • (2003) Vaccine , vol.21 , Issue.24 , pp. 3365-3369
    • Simister, N.E.1
  • 140
    • 79953281856 scopus 로고    scopus 로고
    • The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: A review
    • Krieckaert CL, Bartelds GM, Lems WF et al. The effect of immunomodulators on the immunogenicity of TNF-blocking therapeutic monoclonal antibodies: a review. Arthritis Res Ther 2010; 12: 217.
    • (2010) Arthritis Res Ther , vol.12 , pp. 217
    • Krieckaert, C.L.1    Bartelds, G.M.2    Lems, W.F.3
  • 141
    • 65249090248 scopus 로고    scopus 로고
    • Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (AS)
    • de Vries MK, vander Horst-Bruinsma IE, Nurmohamed MT et al. Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis (AS). Ann Rheum Dis 2009;68:531-535.
    • (2009) Ann Rheum Dis , vol.68 , pp. 531-535
    • de Vries, M.K.1    vander Horst-Bruinsma, I.E.2    Nurmohamed, M.T.3
  • 142
    • 24344471811 scopus 로고    scopus 로고
    • British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005
    • Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler D, et al. British Association of Dermatologists guidelines for use of biological interventions in psoriasis 2005. Br J Dermatol 2005;153:486-497.
    • (2005) Br J Dermatol , vol.153 , pp. 486-497
    • Smith, C.H.1    Anstey, A.V.2    Barker, J.N.3    Burden, A.D.4    Chalmers, R.J.5    Chandler, D.6
  • 144
    • 67650096563 scopus 로고    scopus 로고
    • Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
    • Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 2009;60:1884-1894.
    • (2009) Arthritis Rheum , vol.60 , pp. 1884-1894
    • Tubach, F.1    Salmon, D.2    Ravaud, P.3    Allanore, Y.4    Goupille, P.5    Breban, M.6
  • 145
    • 33748936662 scopus 로고    scopus 로고
    • Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study
    • Gordon KB, Langley RG, Leonardi C, Toth D, Menter MA, Kang S, et al.Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: double-blind, randomized controlled trial and open-label extension study. J Am Acad Dermatol 2006;55(4):598-606.
    • (2006) J Am Acad Dermatol , vol.55 , Issue.4 , pp. 598-606
    • Gordon, K.B.1    Langley, R.G.2    Leonardi, C.3    Toth, D.4    Menter, M.A.5    Kang, S.6
  • 146
  • 149
    • 29844440963 scopus 로고    scopus 로고
    • Etanercept and clinical outcomes, fatigue, and depression in psoriasis: Double-blind placebocontrolled randomised phase III trial
    • Jan 7
    • Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebocontrolled randomised phase III trial. Lancet. 2006 Jan 7;367(9504):29-35.
    • (2006) Lancet , vol.367 , Issue.9504 , pp. 29-35
    • Tyring, S.1    Gottlieb, A.2    Papp, K.3    Gordon, K.4    Leonardi, C.5    Wang, A.6
  • 150
    • 21644481166 scopus 로고    scopus 로고
    • A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction
    • Jun
    • Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, et al. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction. Br J Dermatol. 2005 Jun;152(6):1304-1312.
    • (2005) Br J Dermatol , vol.152 , Issue.6 , pp. 1304-1312
    • Papp, K.A.1    Tyring, S.2    Lahfa, M.3    Prinz, J.4    Griffiths, C.E.5    Nakanishi, A.M.6
  • 151
    • 19044382942 scopus 로고    scopus 로고
    • Infliximab improves signs and symptoms of psoriatic arthritis: Results of the IMPACT 2 trial
    • Antoni C, Krueger GG, de Vlam K, Birbara C, Beutler A, Guzzo C, et al. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005;64 (8):1150-1157.
    • (2005) Ann Rheum Dis , vol.64 , Issue.8 , pp. 1150-1157
    • Antoni, C.1    Krueger, G.G.2    de Vlam, K.3    Birbara, C.4    Beutler, A.5    Guzzo, C.6
  • 152
    • 33845692734 scopus 로고    scopus 로고
    • A randomized comparison of continuous vs. Intermittent infliximab maintenance regimens over 1 year in the treatment of moderate to severe plaque psoriasis
    • Menter A, Feldman SR, Weinstein GD, Papp K, Evans R, Guzzo C, et al. A randomized comparison of continuous vs. Intermittent infliximab maintenance regimens over 1 year in the treatment of moderate to severe plaque psoriasis. J Am Acad Dermatol 2007;56(1):31.e1-15.
    • (2007) J Am Acad Dermatol , vol.56 , Issue.1
    • Menter, A.1    Feldman, S.R.2    Weinstein, G.D.3    Papp, K.4    Evans, R.5    Guzzo, C.6
  • 153
    • 26644433889 scopus 로고    scopus 로고
    • Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial
    • Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, et al. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial. Lancet 2005;366(9494):1367-1374.
    • (2005) Lancet , vol.366 , Issue.9494 , pp. 1367-1374
    • Reich, K.1    Nestle, F.O.2    Papp, K.3    Ortonne, J.P.4    Evans, R.5    Guzzo, C.6
  • 154
    • 4644327125 scopus 로고    scopus 로고
    • Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial
    • Gottlieb AB, Evans R, Li S, Dooley LT, Guzzo CA, Baker D, et al. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 2004;51(4):534-542.
    • (2004) J Am Acad Dermatol , vol.51 , Issue.4 , pp. 534-542
    • Gottlieb, A.B.1    Evans, R.2    Li, S.3    Dooley, L.T.4    Guzzo, C.A.5    Baker, D.6
  • 155
    • 43449111187 scopus 로고    scopus 로고
    • Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebocontrolled trial (phoenix 1)
    • Leonardi C, Kimball AB, Papp KA, Yeilding N, Guzzo C, Wang Y, et al. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebocontrolled trial (phoenix 1). The Lancet. 2008;371:1665-1674.
    • (2008) The Lancet , vol.371 , pp. 1665-1674
    • Leonardi, C.1    Kimball, A.B.2    Papp, K.A.3    Yeilding, N.4    Guzzo, C.5    Wang, Y.6
  • 156
    • 79953111225 scopus 로고    scopus 로고
    • Responses to ustekinumab in the anti TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris
    • Sep
    • Clemmensen A, Spon M, Skov L, Zachariae C, Gniadecki R. Responses to ustekinumab in the anti TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2011 Sep;25(9):1037-40.
    • (2011) J Eur Acad Dermatol Venereol , vol.25 , Issue.9 , pp. 1037-1040
    • Clemmensen, A.1    Spon, M.2    Skov, L.3    Zachariae, C.4    Gniadecki, R.5
  • 157
    • 79955386416 scopus 로고    scopus 로고
    • Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris
    • Gniadecki R, Kragballe K, Dam TN, Skov L. Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris. Br J Dermatol. 2011 Jan 11.
    • (2011) Br J Dermatol , pp. 11
    • Gniadecki, R.1    Kragballe, K.2    Dam, T.N.3    Skov, L.4
  • 158
    • 33748442129 scopus 로고    scopus 로고
    • Initial experience with routine administration of etanercept in psoriasis
    • de Groot M, Appelman M, Spuls PI, De Rie MA, Bos JD. Initial experience with routine administration of etanercept in psoriasis. Br J Dermatol. 2006;155:808-14.
    • (2006) Br J Dermatol , vol.155 , pp. 808-814
    • de Groot, M.1    Appelman, M.2    Spuls, P.I.3    de Rie, M.A.4    Bos, J.D.5
  • 159
    • 76749092658 scopus 로고    scopus 로고
    • Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis
    • Lecluse LL, Driessen RJ, Spuls PI, de Jong EM, Stapel SO, van Doorn MB, et al. Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis. Arch Dermatol. 2010;146(2):127-32.
    • (2010) Arch Dermatol , vol.146 , Issue.2 , pp. 127-132
    • Lecluse, L.L.1    Driessen, R.J.2    Spuls, P.I.3    de Jong, E.M.4    Stapel, S.O.5    van Doorn, M.B.6
  • 160
    • 33750524246 scopus 로고    scopus 로고
    • Etanercept and infliximab for the treatment of psoriatic arthritis: A systematic review and economic evaluation
    • Woolacott N, Vergel BY, Hawkins N, Kainth A, Khadjesari Z, Misso K, et al. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation. Health Technol Assess. 2006;10(31): 1-239.
    • (2006) Health Technol Assess , vol.10 , Issue.31 , pp. 1-239
    • Woolacott, N.1    Vergel, B.Y.2    Hawkins, N.3    Kainth, A.4    Khadjesari, Z.5    Misso, K.6
  • 161
    • 28444454046 scopus 로고    scopus 로고
    • How patients experience psoriasis: Results from a European survey
    • Fauéré S, Adjadj L, Pawin H. How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol. 2005;19:2-6.
    • (2005) J Eur Acad Dermatol , vol.19 , pp. 2-6
    • Fauéré, S.1    Adjadj, L.2    Pawin, H.3
  • 162
    • 33748448266 scopus 로고    scopus 로고
    • On behalf of the EUROPSO patient survey. European patient perspectives on the impact at psoriasis: The EUROPSO patient membership survey
    • Dubertret L, Mrowietz U, Ranki A, van de Kerkhof PC, Chimenti T, Lotti T, et al. On behalf of the EUROPSO patient survey. European patient perspectives on the impact at psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006;155:729-736.
    • (2006) Br J Dermatol , vol.155 , pp. 729-736
    • Dubertret, L.1    Mrowietz, U.2    Ranki, A.3    van de Kerkhof, P.C.4    Chimenti, T.5    Lotti, T.6
  • 163
    • 0033918656 scopus 로고    scopus 로고
    • Patient compliance and disease management in the treatment of psoriasis in the Netherlands
    • van de Kerkhof PC, de Hoop D, de Korte J, Cobelens SA, Kuipers MV. Patient compliance and disease management in the treatment of psoriasis in the Netherlands. Dermatology 2000;200:292-299.
    • (2000) Dermatology , vol.200 , pp. 292-299
    • van de Kerkhof, P.C.1    de Hoop, D.2    de Korte, J.3    Cobelens, S.A.4    Kuipers, M.V.5
  • 164
    • 85047689701 scopus 로고
    • Psoriasis: A questionnaire survey of 2,144 patients
    • Farber EM, Bright RD, Nall ML. Psoriasis: a questionnaire survey of 2,144 patients. Arch Dermatol 1968;98:248-259.
    • (1968) Arch Dermatol , vol.98 , pp. 248-259
    • Farber, E.M.1    Bright, R.D.2    Nall, M.L.3
  • 165
    • 0016229099 scopus 로고
    • The natural history of psoriasis in 5,600 patients
    • Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974;148:1-18.
    • (1974) Dermatologica , vol.148 , pp. 1-18
    • Farber, E.M.1    Nall, M.L.2
  • 166
    • 19544377374 scopus 로고    scopus 로고
    • Clinical analysis of 48 cases of inverse psoriasis: A hospital based study
    • Wang G, Li C, Gao T, Liu Y. Clinical analysis of 48 cases of inverse psoriasis: a hospital based study. Eur J Dermatol 2005;15(3):176-178.
    • (2005) Eur J Dermatol , vol.15 , Issue.3 , pp. 176-178
    • Wang, G.1    Li, C.2    Gao, T.3    Liu, Y.4
  • 167
    • 0025112753 scopus 로고
    • Childhood psoriasis: An epidemiological survey of 112 patients
    • Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiological survey of 112 patients. Pediatr Dermatol 1990;7:19-21.
    • (1990) Pediatr Dermatol , vol.7 , pp. 19-21
    • Nanda, A.1    Kaur, S.2    Kaur, I.3    Kumar, B.4
  • 168
    • 0006458953 scopus 로고
    • Psoriasis in children under the age of ten: A study of 100 observations
    • Puissant A. Psoriasis in children under the age of ten: a study of 100 observations. Gazz Sanitaria 1970;19:191-198.
    • (1970) Gazz Sanitaria , vol.19 , pp. 191-198
    • Puissant, A.1
  • 169
    • 0016648790 scopus 로고
    • Psoriasis in children: A short review and a survey of 245 patients
    • Nyfors A, Lemholt K. Psoriasis in children: a short review and a survey of 245 patients. Br J Dermatol 1975;92:437-448.
    • (1975) Br J Dermatol , vol.92 , pp. 437-448
    • Nyfors, A.1    Lemholt, K.2
  • 170
    • 1642376048 scopus 로고    scopus 로고
    • Facial psoriasis: Comparison of patients with and without facial involvement
    • Park JY, Rim JH, Choe YB, Youn YI. Facial psoriasis: comparison of patients with and without facial involvement. J Am Acad Dermatol 2004;50:582-584.
    • (2004) J Am Acad Dermatol , vol.50 , pp. 582-584
    • Park, J.Y.1    Rim, J.H.2    Choe, Y.B.3    Youn, Y.I.4
  • 171
    • 43249093867 scopus 로고    scopus 로고
    • Classification of facial psoriasis based on the distributions of facial lesions
    • Woo SM, Choi JW, Yoon HS, Jo SJ, Youn JI. Classification of facial psoriasis based on the distributions of facial lesions. J Am Acad Dermatol 2008;58:959-963.
    • (2008) J Am Acad Dermatol , vol.58 , pp. 959-963
    • Woo, S.M.1    Choi, J.W.2    Yoon, H.S.3    Jo, S.J.4    Youn, J.I.5
  • 173
    • 84944373068 scopus 로고
    • Psoriasis: A statistical study of 231 cases
    • Lane CG, Craford GM. Psoriasis: a statistical study of 231 cases. Arch Dermatol 1937;35:1051-61.
    • (1937) Arch Dermatol , vol.35 , pp. 1051-1061
    • Lane, C.G.1    Craford, G.M.2
  • 176
    • 0034103482 scopus 로고    scopus 로고
    • Treatment with psoriasis with an antiseptic combination, in a doubleblind comparison versus eosin
    • Leigheb G, Gallus D, Spano G. Treatment with psoriasis with an antiseptic combination, in a doubleblind comparison versus eosin. G Ital Dermatol Venereol 2000;135:107-114.
    • (2000) G Ital Dermatol Venereol , vol.135 , pp. 107-114
    • Leigheb, G.1    Gallus, D.2    Spano, G.3
  • 177
    • 0022413390 scopus 로고
    • Therapy and etiology of sebopsoriasis
    • Doering HF. Therapy and etiology of sebopsoriasis. Z Hautkr 1985;6:1940-1950.
    • (1985) Z Hautkr , vol.6 , pp. 1940-1950
    • Doering, H.F.1
  • 178
    • 0022393304 scopus 로고
    • Treatment of sebopsoriasis with itraconazole
    • Faergemann J. Treatment of sebopsoriasis with itraconazole. Mykoses 1985;28:612-618.
    • (1985) Mykoses , vol.28 , pp. 612-618
    • Faergemann, J.1
  • 179
    • 0024513252 scopus 로고
    • Niedrig konzentriertes Dithranol bei Psoriasis des Gesichtes
    • Heller G. Niedrig konzentriertes Dithranol bei Psoriasis des Gesichtes. Dermatol Monatschr 1989;175:35-39.
    • (1989) Dermatol Monatschr , vol.175 , pp. 35-39
    • Heller, G.1
  • 180
    • 33748785967 scopus 로고    scopus 로고
    • 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: A doubleblind, randomized controlled study
    • Kreuter A, Sommer A, Hyun J, Brautigam M, Brockmeyer NH, Altmeyer P, et al. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a doubleblind, randomized controlled study. Arch Dermatol. 2006;142:1138-1143.
    • (2006) Arch Dermatol , vol.142 , pp. 1138-1143
    • Kreuter, A.1    Sommer, A.2    Hyun, J.3    Brautigam, M.4    Brockmeyer, N.H.5    Altmeyer, P.6
  • 181
    • 0035135753 scopus 로고    scopus 로고
    • Limited application of fluticasone propionate ointment 0,005% in patients with psoriasis of the face and intertriginous areas
    • Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment 0,005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol 2001;44:77-82.
    • (2001) J Am Acad Dermatol , vol.44 , pp. 77-82
    • Lebwohl, M.G.1    Tan, M.H.2    Meador, S.L.3    Singer, G.4
  • 182
    • 35348855190 scopus 로고    scopus 로고
    • Comparison of cutaneous tolerance and efficacy of calcitriol 3 ug/g ointment and tacrolimus 0,3 mg/g ointment in chronic plaque psoriasis involving facial or genitofemoral areas: A double-blind, randomized controlled trial
    • Liao YH, Chiu HC, Tseng YS, Tsai EF. Comparison of cutaneous tolerance and efficacy of calcitriol 3 ug/g ointment and tacrolimus 0,3 mg/g ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. British Journal of Dermatology 2007;157:1005-1012.
    • (2007) British Journal of Dermatology , vol.157 , pp. 1005-1012
    • Liao, Y.H.1    Chiu, H.C.2    Tseng, Y.S.3    Tsai, E.F.4
  • 183
    • 0037325836 scopus 로고    scopus 로고
    • Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3mcg g-1 ointment and calcipotriol 50 mcg g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauriculair or flexural areas
    • Ortonne JP, Humbert P, Nicolas JF, Tsankov N, Tonev SD, Janin A, et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3mcg g-1 ointment and calcipotriol 50 mcg g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauriculair or flexural areas. Br J Dermatol 2003;148:326-333.
    • (2003) Br J Dermatol , vol.148 , pp. 326-333
    • Ortonne, J.P.1    Humbert, P.2    Nicolas, J.F.3    Tsankov, N.4    Tonev, S.D.5    Janin, A.6
  • 184
    • 3042778913 scopus 로고    scopus 로고
    • Calcipotriol cream in the treatment of flexural psoriasis
    • Duweb GA, Eldebani S, Alhaddar J. Calcipotriol cream in the treatment of flexural psoriasis. Int J Tissue React 2003; 25:127-130.
    • (2003) Int J Tissue React , vol.25 , pp. 127-130
    • Duweb, G.A.1    Eldebani, S.2    Alhaddar, J.3
  • 185
    • 0029799913 scopus 로고    scopus 로고
    • Topical Calcipotriol in the treatment of intertriginous psoriasis
    • Kienbaum S, Lehmann P, Ruzicka T. Topical Calcipotriol in the treatment of intertriginous psoriasis. Br J Dermatol 1996; 135:647-650.
    • (1996) Br J Dermatol , vol.135 , pp. 647-650
    • Kienbaum, S.1    Lehmann, P.2    Ruzicka, T.3
  • 186
    • 0029825237 scopus 로고    scopus 로고
    • Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis
    • Langer A, Stapor V, Verjans H, Elzerman J. Calcitriol ointment in the treatment of facial, hairline and retroauricular chronic plaque psoriasis. J Dermatol Treat 1996;7(Suppl.l):S15-S18.
    • (1996) J Dermatol Treat , vol.7 , Issue.SUPPL. l
    • Langer, A.1    Stapor, V.2    Verjans, H.3    Elzerman, J.4
  • 188
    • 8744304117 scopus 로고    scopus 로고
    • Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
    • Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol 2004;51:731-738.
    • (2004) J Am Acad Dermatol , vol.51 , pp. 731-738
    • Gribetz, C.1    Ling, M.2    Lebwohl, M.3    Pariser, D.4    Draelos, Z.5    Gottlieb, A.B.6
  • 189
    • 33646543597 scopus 로고    scopus 로고
    • The efficacy of 0.1% tacrolimus ointment compared with clobetasonebutyrate 0.05% ointment in patients with facial flexural or genital psoriasis
    • Kleyn CE, Woodcock D, Sharpe GR. The efficacy of 0.1% tacrolimus ointment compared with clobetasonebutyrate 0.05% ointment in patients with facial flexural or genital psoriasis. Br J Dermatol 2005;153(Suppl.1):33.
    • (2005) Br J Dermatol , vol.153 , Issue.SUPPL. 1 , pp. 33
    • Kleyn, C.E.1    Woodcock, D.2    Sharpe, G.R.3
  • 191
    • 0025830166 scopus 로고
    • Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis
    • Herz G, Blum G, Yawalkar S. Halobetasol propionate cream by day and halobetasol propionate ointment at night for the treatment of pediatric patients with chronic, localized plaque psoriasis and atopic dermatitis. J Am Acad Dermatol 1991;25:1166-1169.
    • (1991) J Am Acad Dermatol , vol.25 , pp. 1166-1169
    • Herz, G.1    Blum, G.2    Yawalkar, S.3
  • 192
    • 48749099907 scopus 로고    scopus 로고
    • Clobetasol propionate emulsion formulation foam 0.05%; review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents
    • Kimball AB, Gold MH, Zib B, Davis MW. Clobetasol propionate emulsion formulation foam 0.05%; review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. J Am Acad Dermatol 2008;59:448-454.
    • (2008) J Am Acad Dermatol , vol.59 , pp. 448-454
    • Kimball, A.B.1    Gold, M.H.2    Zib, B.3    Davis, M.W.4
  • 195
    • 0029111614 scopus 로고
    • Pilot study of topical calcitriol (1, 25-dihydroxyvitamin D3) for treating psoriasis in children
    • Perez A, Chen TC, Turner A, Holick MF. Pilot study of topical calcitriol (1, 25-dihydroxyvitamin D3) for treating psoriasis in children. Arch Dermatol 1995;131:961-962.
    • (1995) Arch Dermatol , vol.131 , pp. 961-962
    • Perez, A.1    Chen, T.C.2    Turner, A.3    Holick, M.F.4
  • 196
    • 33846960746 scopus 로고    scopus 로고
    • Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients
    • Brune A, Miller DW, Lin P, Cotrim-Russi D, Paller AS. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients. Pediatr Dermatol 2007;24:76-80.
    • (2007) Pediatr Dermatol , vol.24 , pp. 76-80
    • Brune, A.1    Miller, D.W.2    Lin, P.3    Cotrim-Russi, D.4    Paller, A.S.5
  • 197
    • 25844470461 scopus 로고    scopus 로고
    • Topical tacrolimus in the treatment of inverse psoriasis in children
    • Steele JA, Choi C, Kwong PC. Topical tacrolimus in the treatment of inverse psoriasis in children. J Am Acad Dermatol 2005;53:713-716.
    • (2005) J Am Acad Dermatol , vol.53 , pp. 713-716
    • Steele, J.A.1    Choi, C.2    Kwong, P.C.3
  • 198
    • 7244236616 scopus 로고    scopus 로고
    • Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream
    • Amichai B. Psoriasis of the glans penis in a child successfully treated with Elidel (pimecrolimus) cream. J Eur Acad Dermatol Venereol 2004;18:742-743.
    • (2004) J Eur Acad Dermatol Venereol , vol.18 , pp. 742-743
    • Amichai, B.1
  • 199
    • 33748459660 scopus 로고    scopus 로고
    • Pimecrolimus 1 percent cream in the treatment of psoriasis in a child
    • Mansouri P, Farshi S. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child. Dermatol Online J 2006;12:7.
    • (2006) Dermatol Online J , vol.12 , pp. 7
    • Mansouri, P.1    Farshi, S.2
  • 200
    • 0028081038 scopus 로고
    • Efficacy of short-contact therapy with dithranol in childhood psoriasis
    • Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol 1994;33:808-810.
    • (1994) Int J Dermatol , vol.33 , pp. 808-810
    • Zvulunov, A.1    Anisfeld, A.2    Metzker, A.3
  • 201
    • 0020535957 scopus 로고
    • An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children
    • Guerrier CJ, Porter DI. An open assessment of 0.1% dithranol in a 17% urea base ('Psoradrate' 0.1%) in the treatment of psoriasis of children. Curr Med Res Opin 1983;8:446-450.
    • (1983) Curr Med Res Opin , vol.8 , pp. 446-450
    • Guerrier, C.J.1    Porter, D.I.2
  • 203
    • 0028912957 scopus 로고
    • UVB phototherapy in childhood psoriasis
    • al-Fouzan AS, Nanda A. UVB phototherapy in childhood psoriasis. Pediatr Dermatol 1995;12:66.
    • (1995) Pediatr Dermatol , vol.12 , pp. 66
    • Al-Fouzan, A.S.1    Nanda, A.2
  • 204
    • 33847794650 scopus 로고    scopus 로고
    • Narrow-band UV-B phototherapy in childhood psoriasis
    • Jain VK, Aggarwal K, Jain K, Bansal A. Narrow-band UV-B phototherapy in childhood psoriasis. Int J Dermatol 2007;46:320-322.
    • (2007) Int J Dermatol , vol.46 , pp. 320-322
    • Jain, V.K.1    Aggarwal, K.2    Jain, K.3    Bansal, A.4
  • 207
  • 209
    • 33748894210 scopus 로고    scopus 로고
    • Suit PUVA as an effective and safe modality of treatment in guttate psoriasis
    • Thappa DM, Laxmisha C. Suit PUVA as an effective and safe modality of treatment in guttate psoriasis. J Eur Acad Dermatol Venereol 2006;20:1146-1147.
    • (2006) J Eur Acad Dermatol Venereol , vol.20 , pp. 1146-1147
    • Thappa, D.M.1    Laxmisha, C.2
  • 210
    • 0028241958 scopus 로고
    • Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis; a study of five cases
    • Patrizi A, Costa AM, Fiorillo L, Neri I. Perianal streptococcal dermatitis associated with guttate psoriasis and/or balanoposthitis; a study of five cases. Pediatr Dermatol 1994;11:168-171.
    • (1994) Pediatr Dermatol , vol.11 , pp. 168-171
    • Patrizi, A.1    Costa, A.M.2    Fiorillo, L.3    Neri, I.4
  • 211
    • 0027421652 scopus 로고
    • Acute guttate psoriasis after streptococcal scarlet fever [2]
    • Pacifico L. Acute guttate psoriasis after streptococcal scarlet fever [2]. Pediatric-Dermatology 1993;10:388-389.
    • (1993) Pediatric-Dermatology , vol.10 , pp. 388-389
    • Pacifico, L.1
  • 213
    • 0021966558 scopus 로고
    • Generalized pustular psoriasis in a child
    • van de Kerkhof PC. Generalized pustular psoriasis in a child. Dermatologica 1985; 170:244-248.
    • (1985) Dermatologica , vol.170 , pp. 244-248
    • van de Kerkhof, P.C.1
  • 214
    • 84896460469 scopus 로고
    • In; Farber EM, Cox AJ, editors. Proceedings of the 4th international symposium on psoriasis, Stanford University.Stanford; University Press
    • Pavicic Z, Kmet-Vizitin P, Kansky A. Etretinate in treating juvenile generalized pustular psoriasis. In; Farber EM, Cox AJ, editors. Proceedings of the 4th international symposium on psoriasis, Stanford University.Stanford; University Press; 1986. p. 467.
    • (1986) Etretinate In Treating Juvenile Generalized Pustular Psoriasis , pp. 467
    • Pavicic, Z.1    Kmet-Vizitin, P.2    Kansky, A.3
  • 217
    • 0041632229 scopus 로고    scopus 로고
    • Oral retinoid therapy for dermatologic conditions in children and adolescents
    • Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003;49:171-82.
    • (2003) J Am Acad Dermatol , vol.49 , pp. 171-182
    • Brecher, A.R.1    Orlow, S.J.2
  • 220
    • 0031669455 scopus 로고    scopus 로고
    • The use of cyclosporin in a child with generalized pustular psoriasis
    • Alli N, Gungor E, Karakayali G, Lenk N, Artuz F. The use of cyclosporin in a child with generalized pustular psoriasis. Br J Dermatol 1998;139:754-755.
    • (1998) Br J Dermatol , vol.139 , pp. 754-755
    • Alli, N.1    Gungor, E.2    Karakayali, G.3    Lenk, N.4    Artuz, F.5
  • 221
    • 33751366493 scopus 로고    scopus 로고
    • Photosensitive psoriasis in a vitiligo patient
    • Torchia D, Terranova M, Fabbri P. Photosensitive psoriasis in a vitiligo patient. J Dermatol 2006;33:880-883.
    • (2006) J Dermatol , vol.33 , pp. 880-883
    • Torchia, D.1    Terranova, M.2    Fabbri, P.3
  • 222
    • 0033959268 scopus 로고    scopus 로고
    • Cyclosporin for severe childhood atopic dermatitis; short course versus continuous therapy
    • Harper JI, Ahmed I, Barclay G, Lacour M, Hoeger P, Cork MJ, et al. Cyclosporin for severe childhood atopic dermatitis; short course versus continuous therapy. Br J Dermatol 2000;142:52-8.
    • (2000) Br J Dermatol , vol.142 , pp. 52-58
    • Harper, J.I.1    Ahmed, I.2    Barclay, G.3    Lacour, M.4    Hoeger, P.5    Cork, M.J.6
  • 223
    • 31644442734 scopus 로고    scopus 로고
    • The use of ciclosporin in psoriasis
    • Berth-Jones J. The use of ciclosporin in psoriasis. J Dermatolog Treat 2005;16:258-77.
    • (2005) J Dermatolog Treat , vol.16 , pp. 258-277
    • Berth-Jones, J.1
  • 224
    • 34247391964 scopus 로고    scopus 로고
    • Methotrexate therapy in 10 children with severe plaque psoriasis; P-29
    • Collin B, Ogboli M, Moss C. Methotrexate therapy in 10 children with severe plaque psoriasis; P-29. British Journal of Dermatology 2006;155(Suppl 1):33.
    • (2006) British Journal of Dermatology , vol.155 , Issue.SUPPL. 1 , pp. 33
    • Collin, B.1    Ogboli, M.2    Moss, C.3
  • 225
    • 42549115308 scopus 로고    scopus 로고
    • Systemic methotrexate treatment in childhood psoriasis; further experience in 24 children from India
    • Kaur I, Dogra S, De D, Kanwar AJ. Systemic methotrexate treatment in childhood psoriasis; further experience in 24 children from India. Pediatr Dermatol 2008;25:184-188.
    • (2008) Pediatr Dermatol , vol.25 , pp. 184-188
    • Kaur, I.1    Dogra, S.2    De, D.3    Kanwar, A.J.4
  • 227
    • 0030063801 scopus 로고    scopus 로고
    • Juvenile generalized pustular psoriasis
    • Kalla G, Goyal AM. Juvenile generalized pustular psoriasis. Pediatr Dermatol 1996;13:45-46.
    • (1996) Pediatr Dermatol , vol.13 , pp. 45-46
    • Kalla, G.1    Goyal, A.M.2
  • 228
    • 2942562635 scopus 로고    scopus 로고
    • Methotrexate in severe childhood psoriasis
    • Dogra S, Handa S, Kanwar AJ. Methotrexate in severe childhood psoriasis. Pediatr Dermatol 2004;21:283-284.
    • (2004) Pediatr Dermatol , vol.21 , pp. 283-284
    • Dogra, S.1    Handa, S.2    Kanwar, A.J.3
  • 229
    • 12944289608 scopus 로고    scopus 로고
    • Methotrexate for generalized pustular psoriasis in a 2-year-old child
    • Dogra S, Kumaran MS, Handa S, Kanwar AJ. Methotrexate for generalized pustular psoriasis in a 2-year-old child. Pediatr Dermatol 2005;22:85-86.
    • (2005) Pediatr Dermatol , vol.22 , pp. 85-86
    • Dogra, S.1    Kumaran, M.S.2    Handa, S.3    Kanwar, A.J.4
  • 231
    • 43949143169 scopus 로고    scopus 로고
    • Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
    • Lovell DJ, Reiff A, Ilowite NT, Wallace CA, Chon Y, Lin SL, et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. Arthritis Rheum 2008;58:1496-504.
    • (2008) Arthritis Rheum , vol.58 , pp. 1496-1504
    • Lovell, D.J.1    Reiff, A.2    Ilowite, N.T.3    Wallace, C.A.4    Chon, Y.5    Lin, S.L.6
  • 234
    • 29844443537 scopus 로고    scopus 로고
    • Successful use of infliximab following a failed course of etanercept in a pediatric patient
    • Farnsworth NN, George SJ, Hsu S. Successful use of infliximab following a failed course of etanercept in a pediatric patient. Dermatol Online J 2005;11:11.
    • (2005) Dermatol Online J , vol.11 , pp. 11
    • Farnsworth, N.N.1    George, S.J.2    Hsu, S.3
  • 235
    • 1342346479 scopus 로고    scopus 로고
    • Successful treatment of pediatric psoriasis with infliximab
    • Menter MA, Cush JM. Successful treatment of pediatric psoriasis with infliximab. Pediatr Dermatol 2004;21:87-88.
    • (2004) Pediatr Dermatol , vol.21 , pp. 87-88
    • Menter, M.A.1    Cush, J.M.2
  • 237
    • 33748949565 scopus 로고    scopus 로고
    • Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment
    • Lin YK, Yen HR, Wong WR, Yang SH, Pang JH. Successful treatment of pediatric psoriasis with Indigo naturalis composite ointment. Pediatr Dermatol 2006;23:507-510.
    • (2006) Pediatr Dermatol , vol.23 , pp. 507-510
    • Lin, Y.K.1    Yen, H.R.2    Wong, W.R.3    Yang, S.H.4    Pang, J.H.5
  • 238
    • 16344376729 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children; a pilot study
    • Pahlajani N, Katz BJ, Lozano AM, Murphy F, Gottlieb A. Comparison of the efficacy and safety of the 308 nm excimer laser for the treatment of localized psoriasis in adults and in children; a pilot study. Pediatr Dermatol 2005;22:161-165.
    • (2005) Pediatr Dermatol , vol.22 , pp. 161-165
    • Pahlajani, N.1    Katz, B.J.2    Lozano, A.M.3    Murphy, F.4    Gottlieb, A.5
  • 241
    • 1242269965 scopus 로고    scopus 로고
    • Successive use of fumaric acid esters for the treatment of psoriasis vulgaris in a 14-year old patient
    • Gunther CH. Successive use of fumaric acid esters for the treatment of psoriasis vulgaris in a 14-year old patient. Haut-2004;15:28-30.
    • (2004) Haut , vol.15 , pp. 28-30
    • Gunther, C.H.1
  • 242
    • 0034923524 scopus 로고    scopus 로고
    • A case of childhood generalized pustular psoriasis treated with dapsone
    • Yu HJ, Park JW, Park JM, Hwang DK, Park YW. A case of childhood generalized pustular psoriasis treated with dapsone. J Dermatol 2001;28:316-319.
    • (2001) J Dermatol , vol.28 , pp. 316-319
    • Yu, H.J.1    Park, J.W.2    Park, J.M.3    Hwang, D.K.4    Park, Y.W.5
  • 245
  • 247
    • 0019126864 scopus 로고
    • Therapeutic trials with oral colchicine in psoriasis
    • Wahba A, Cohen H. Therapeutic trials with oral colchicine in psoriasis. Acta Derm Venereol 1980;60:515-520.
    • (1980) Acta Derm Venereol , vol.60 , pp. 515-520
    • Wahba, A.1    Cohen, H.2
  • 248
    • 0020404419 scopus 로고
    • Colchicine in generalized pustular psoriasis; clinical response and antibodydependent cytotoxicity by monocytes and neutrophils
    • Zachariae H, Kragballe K, Herlin T. Colchicine in generalized pustular psoriasis; clinical response and antibodydependent cytotoxicity by monocytes and neutrophils. Arch Dermatol Res 1982;274:327-333.
    • (1982) Arch Dermatol Res , vol.274 , pp. 327-333
    • Zachariae, H.1    Kragballe, K.2    Herlin, T.3
  • 250
    • 4243119542 scopus 로고    scopus 로고
    • Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease
    • Atkinson MJ, Sinha A, Hass SL et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004;2:12.
    • (2004) Health Qual Life Outcomes , vol.2 , pp. 12
    • Atkinson, M.J.1    Sinha, A.2    Hass, S.L.3
  • 251
    • 52749091357 scopus 로고    scopus 로고
    • Development and validation of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)
    • Ruiz MA, Pardo A, Rejas J, Soto J, Vallisante F, Aranguren JL. Development and validation of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q). Value Health 2008;11:913-926.
    • (2008) Value Health , vol.11 , pp. 913-926
    • Ruiz, M.A.1    Pardo, A.2    Rejas, J.3    Soto, J.4    Vallisante, F.5    Aranguren, J.L.6
  • 252


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.